Angeles Alvarez Secord

Title: Angeles Alvarez Secord: Innovator in Ovarian Cancer Research

Introduction

Angeles Alvarez Secord is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of oncology, particularly in the area of ovarian cancer research. Her work focuses on developing biomarkers that can aid in the prognosis and treatment of high-grade serous ovarian carcinomas.

Latest Patents

Secord holds a patent titled "Biomarkers of high-grade serous ovarian carcinomas." This patent provides valuable biomarkers that are useful for determining the prognosis of conditions such as ovarian cancer. The disclosed subject matter includes angiogenic biomarkers and methods for predicting overall survival (OS) in women diagnosed with high-grade serous carcinomas (HGSCs). The innovations presented in this patent enable rationally directed therapies aimed at improving outcomes for women suffering from HGSC.

Career Highlights

Secord is affiliated with Duke University, where she continues her research and development efforts. Her work has garnered attention for its potential to change the landscape of ovarian cancer treatment and improve patient outcomes.

Collaborations

Throughout her career, Angeles has collaborated with notable colleagues, including Sharareh Reihani and Mark W Dewhirst. These partnerships have further enhanced her research capabilities and broadened the impact of her work.

Conclusion

Angeles Alvarez Secord is a dedicated inventor whose research in ovarian cancer biomarkers holds promise for improving patient prognosis and treatment strategies. Her contributions to the field are invaluable and continue to inspire advancements in cancer research.